James Warner - 14 Dec 2022 Form 4 Insider Report for Criteo S.A. (CRTO)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Dec 2022, 15:16:09 UTC
Prior SEC filing
17 Nov 2022
Next SEC filing
21 Nov 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Ryan Damon, as attorney-in-fact for James Warner

Key filing fact

James Warner filed Form 4 for Criteo S.A. (CRTO) on 15 Dec 2022.

Key facts

  • This page summarizes James Warner's Form 4 filing for Criteo S.A. (CRTO).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 15 Dec 2022, 15:16.

Change

  • Previous filing in this sequence was filed on 17 Nov 2022.
  • Current net transaction value: -$477,666.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRTO transaction

Ordinary Shares

Options Exercise

Transaction value
$209,916
Shares
+20,400
Change %
+74%
Price
$10.29
Shares after
47,953
Date
14 Dec 2022
Ownership
Direct
Footnotes
F1, F2, F3
CRTO transaction

Ordinary Shares

Sale

Transaction value
$528,360
Shares
-20,400
Change %
-43%
Price
$25.90
Shares after
27,553
Date
14 Dec 2022
Ownership
Direct
Footnotes
F1, F3, F4
CRTO transaction

Ordinary Shares

Options Exercise

Transaction value
$104,958
Shares
+10,200
Change %
+37%
Price
$10.29
Shares after
37,753
Date
14 Dec 2022
Ownership
Direct
Footnotes
F1, F2, F3
CRTO transaction

Ordinary Shares

Sale

Transaction value
$264,180
Shares
-10,200
Change %
-27%
Price
$25.90
Shares after
27,553
Date
14 Dec 2022
Ownership
Direct
Footnotes
F1, F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRTO transaction Derivative

Non-employee Warrant (right to buy)

Options Exercise

Transaction value
$0
Shares
-20,400
Change %
-100%
Price
$0.000000*
Shares after
0
Date
14 Dec 2022
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
20,400
Exercise price
$10.29
Footnotes
F1, F2, F3, F5
CRTO transaction Derivative

Non-employee Warrant (right to buy)

Options Exercise

Transaction value
$0
Shares
-10,200
Change %
-100%
Price
$0.000000*
Shares after
0
Date
14 Dec 2022
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
10,200
Exercise price
$10.29
Footnotes
F1, F2, F3, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Footnote F2

The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.29 using the exchange rate as of December 14, 2022 (1.00 = $1.06587).

Footnote F3

For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Footnote F4

The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.94 to $25.54 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F5

Warrant granted on February 7, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on February 7, 2023.

Footnote F6

Warrant granted on March 6, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on March 6, 2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .